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Abstract: Although reclaimed water for potable applications has many potential benefits, it poses
concerns for chemical and microbial risks to consumers. We present a quantitative microbial risk
assessment (QMRA) Monte Carlo framework to compare a de facto water reuse scenario (treated
wastewater-impacted surface water) with four hypothetical Direct Potable Reuse (DPR) scenarios for
Norovirus, Cryptosporidium, and Salmonella. Consumer microbial risks of surface source water quality
(impacted by 0–100% treated wastewater effluent) were assessed. Additionally, we assessed risks for
different blending ratios (0–100% surface water blended into advanced-treated DPR water) when source
surface water consisted of 50% wastewater effluent. De facto reuse risks exceeded the yearly 10−4
infections risk benchmark while all modeled DPR risks were significantly lower. Contamination with
1% or more wastewater effluent in the source water, and blending 1% or more wastewater-impacted
surface water into the advanced-treated DPR water drove the risk closer to the 10−4 benchmark.
We demonstrate that de facto reuse by itself, or as an input into DPR, drives microbial risks more so
than the advanced-treated DPR water. When applied using location-specific inputs, this framework can
contribute to project design and public awareness campaigns to build legitimacy for DPR.
Keywords: reclaimed water; direct potable reuse; quantitative microbial risk assessment (QMRA);
norovirus; Salmonella; Cryptosporidium; blending
1. Introduction
Many arid urban centers in developed and developing countries are struggling to meet their
long-term water needs. In arid regions such as the southwestern US, the situation is exacerbated by
drought and changing weather patterns, making surface water supplies less reliable. As an example,
a three-year drought left California’s largest reservoirs at below half capacity in 2014 because they are
supplied by Northern Sierra watersheds [1]. In the warm and semi-arid regions of the southwestern
US, the volume of wastewater produced in urban municipalities is about 50% to 60% of the total water
supplied [2]. If treated and reused, this reclaimed water can become a sizable component of the water
portfolio of an urban center and can increase resiliency to climate change impacts.
Water reuse in an urban setting can occur in many forms. Both direct and indirect potable reuse
paradigms provide an alternative water source for stressed urban centers without the need for costly
dual-distribution systems. Figure 1 demonstrates the various paradigms of potable reuse. De facto
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reuse occurs when the drinking water supply intake for a community is located downstream of
a wastewater treatment plant (WWTP) discharge of another community [3]. This form of reuse is
unintentional, is often not officially recognized, and is ubiquitous in many parts of the US [3]. In dry
summer months, some rivers can become primarily wastewater effluent discharged from upstream
facilities [4]. Planned reuse can be for either potable uses, such augmenting the community drinking
water supply, or for non-potable uses, such as landscape irrigation [5].
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reclaimed water, monitoring of microbial pathogens is a challenge because their detection limits are 
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Planned potable reuse can further be classified into indirect (IPR) and direct reuse (DPR). Both IPR
and DPR involve augmenting drinking water supplies with reclaimed water, but the presence of
an environmental buffer such as aquifer recharge distinguishes indirect from direct potable reuse.
Use of such a buffer can dispel public distaste for water originating from sewage, and also provides
storage to synchronize demand with supply [4]. Several municipalities in the US and around the world
successfully practice IPR, including Orange County, California; Fairfax County, Virginia; Gwinnett
County, Georgia; and Gerringong, New South Wales, Australia [6]. DPR does not require the presence
of an environmental buffer, and existing water supplies can be augmented directly, either upstream
or downstream of drinking water treatment, and with the option to include an engineered buffer.
The main motivation for DPR is avoiding the infrastructure and cost associated with recharging
groundwater or transporting the water to a reservoir.
Although the use of reclaimed water for potable applications has many potential benefits, its use
poses concerns for both chemical and microbial risks to consumers. Unlike chemical contaminants of
concern in reclaimed water, monitoring of microbial pathogens is a challenge because their detection
limits are typically much higher than the concentrations deemed to be safe. Concerns about pathogen
removal are the critical driver in water reuse system redundancy and reliability. The implement tion
of direct pot bl reuse systems is in the early stages in the US, although DPR has een practiced in
Windhoek, Namibia for several decades [7,8]. Success of potable reuse, particularly DPR, depends on
reliable pathogen removal, and decision-makers need quantitative tools to compare different treatment
scenarios based on consumer health risk, cost, and other utility-specific concerns.
Quantitative microbial risk assessment (QMRA) can be used for the purposes of estimating the
human health risk associated with exposure to waterborne pathogens using a process of hazard
identification, exposure assessment, dose response, and risk characterization [9]. Although currently
no national regulations for direct potable reuse exist in the United States, microbial quality targets
for IPR in California and DPR in Texas use a goal of 1 infection per 10,000 people per year as a risk
benchmark to inform the 12–10–10 pathogen log-reduction values for enteric viruses, Cryptospordium,
and Giardia, respectively [10–13]. Previous work has modelled the microbiological health risks of
various water reuse treatment trains [12,14] as well as de facto reuse [15]. However, the microbiological
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impact of blending highly-treated reclaimed water produced from DPR with conventionally treated
effluent impacted surface water (de facto reuse) has not been explored. Investigating this gap is
important for exploring the significance of source water quality and blending ratios, and developing
a logical rationale for public health-informed blending targets. This is especially relevant as blending
is currently being practiced immediately upstream of drinking water treatment facilities in the United
States, or in the case of Windhoek, Namibia, downstream of a drinking water treatment within the
drinking water distribution system [6,16]. Additionally, no direct comparison has been made between
de facto “status quo” and DPR risks; contextualizing DPR risks within this framework may prove
valuable for informing water reclamation projects in the future as water scarcity continues to increase.
The research objectives for this study were to: (1) compare the microbial risks for four different
DPR configurations alongside a de-facto reuse scenario; (2) show the impact of individual DPR
treatment processes to demonstrate the ones that have the greatest potential for health risk mitigation;
(3) quantify the effect of wastewater effluent-impacted source water quality on health risks during the
blending process; and (4) quantify the impact of blending treated reclaimed water (DPR) water with
conventionally treated de facto reuse water for understanding the impact of blending ratio upstream
from the conventional drinking water treatment process.
2. Materials and Methods
2.1. Hazard Identification
Norovirus (virus), Salmonella spp. (bacteria) and Cryptosporidium spp. (protozoan parasite) were
chosen as representative reference pathogens from each class of water-borne pathogens. Disease
caused by these pathogens constitutes a significant portion of waterborne illnesses in the United
States [17]. Additionally, occurrence, removal, and dose response information was available in the
literature for these pathogens.
2.2. Treatment Train Scenarios
Planned reuse can be implemented via countless technological variations. The choice of the treatment
scheme depends on many factors, such as capital costs, operation and maintenance costs, expertise
required for operation, health risks to the public, disposal of concentrates, energy consumption, and other
considerations [4,18]. Each municipality considering reuse must evaluate a plethora of factors before
making a decision about the most suitable treatment scheme design for their specific situation.
Five treatment configurations representing a spectrum of water reuse scenarios were chosen
for modeling purposes based on a range of options currently in use, or slated for increased future
use, as well as the authors’ professional judgement (Table 1) [6]. Scenario (1) represents de facto
reuse. In this scenario, effluent-impacted source water is treated using conventional drinking water
treatment comprised of chemical coagulation, flocculation, sedimentation, and filtration through
granular media, followed by chlorine disinfection and delivery to the consumer. For the de facto reuse
scenario (and scenarios involving blending with de facto reuse water), various source water qualities
were considered by accounting for the dilution of treated secondary wastewater in the receiving water
body. Pathogen fate and transport was not accounted for as a specific wastewater discharge and/or
water body was not considered. The dilution ratio (ranging from 0 to 100%) was considered to act as
a bulk parameter for source water quality. Scenarios (2), (3), and (5) all have conventional wastewater
treatment as a first step consisting of primary sedimentation and biological treatment with activated
sludge. Scenario (2) treatment is followed with microfiltration (MF), reverse osmosis (RO), ultraviolet
(UV) advanced oxidation (AOP) (UVAOP/UV and hydrogen peroxide quenching), and chlorination.
Scenario (3) conventional wastewater treatment is followed by ozonation (O3), biological activated
carbon (BAC), MF, RO, UVAOP, and chlorination. Scenario (4) consists of primary sedimentation,
membrane bioreactor (MBR), RO, UVAOP, and chlorination, while scenario (5) consists of O3, BAC,
MF, nanofiltration (NF), UVAOP, BAC, and chlorine.
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Table 1. Treatment train scenarios examined for de facto reuse and direct potable reuse (DPR).
Wastewater is shortened to ww. The log removal values used for activated sludge and membrane
bioreactor (MBR) processes include primary sedimentation.
Train
Scenarios
Cases
Considered a Type Source Water Treatment Train Processes
(1) b, c Defacto
Wastewater impacted
surface water
Coagulation/
sedimentation
Media
filtration chlorine
(2) a, c DPR Raw ww Activated sludge MF RO UV/H2O2 chlorine
(3) a, c DPR Raw ww Activated sludge Ozone BAC MF RO UV/H2O2 chlorine
(4) a, c DPR Raw ww MBR RO UV/H2O2 chlorine
(5) a, c DPR Raw ww Activated sludge Ozone BAC MF NF UV/H2O2 BAC chlorine
a See Section 2.5 and Equation (3). Case a: When Fblend = 0, only DPR trains are considered and no blending with
de facto reuse source water is considered but DPR effluent undergoes additional conventional drinking water
treatment; Case b: Fblend = 1, only de facto reuse is considered; Case c: For 0 < Fblend < 1, DPR water is blended
with de facto reuse source water prior to conventional drinking water treatment. For cases b and c, 0 < Fdilution < 1
where 0 is pristine, pathogen-free source-water, and 1 is source water comprised of 100% conventionally-treated
wastewater effluent.
The modeled scenarios represent the typical operational variability in treatment at a plant using
the specific set of conditions described in the input data. These scenarios also do not account for
catastrophic failure of a unit process, such as membrane tearing, which would shut the system down
and rely on treatment redundancy to protect consumers.
The DPR scenarios (2)–(5) model risks only for the advanced-treatment processes mentioned and
do not include blending or additional conventional water treatment that would occur in a functioning
plant (Table 1). Effects of source water quality and blending are considered separately and described
in Section 2.5. Blending highly treated DPR effluent with raw source water for drinking may occur
in-line, in a holding tank or in a reservoir within the plant. For modeling purposes, it is assumed that
untreated source water is blended with highly treated DPR effluent just upstream of the conventional
water treatment processes, resulting in instantaneous and perfect mixing.
2.3. Pathogen Concentrations in Raw Wastewater
Recent reviews [19,20] have addressed the occurrence of norovirus in wastewater. Bootstrapped
estimates of norovirus (genogroups pooled) in raw sewage from North America gave a mean of
103.95 ± 101.10 gene copies per L [19]. Several authors report concentrations of Salmonella in raw
wastewater [21–23] and a lognormal distribution was fit to pool datasets from the two studies where
individual sample data were provided [22,23]. Mean (and standard deviation values reported for
Cryptosporidium in wastewater influent at a full-scale water reclamation facility in St. Petersburg,
Florida were used [24]. Pathogen concentrations are summarized in Table 2.
Table 2. Monte Carlo simulation input parameters for pathogen concentrations.
Parameter Symbol Unit Value Distribution Source
Norovirus Cww,raw,No gene copies per L µ = 9.095, σ = 1.413 × 10−3 Lognormal a [19]
Salmonella spp. Cww,raw,Sa Number per L µ = 7.171, σ = 2.985 Lognormal [22,23]
Cryptosporidium Cww,raw,Cr Number per L µ = 2.262, µ = 0.944 Lognormal [24]
a Lognormal parameters mean, standard deviation (µ, δ) calculated from population (normal) parameters (x, s)
using standard formulae as follows: µ = ln(x2/(s2 + x 2)1/2), δ = [ln(1+( s2/x 2))]1/2, where x is the sample mean
and s2 is the sample standard deviation.
2.4. Pathogen Removals through Unit Process Treatment
For each unit treatment process, the most representative removal and inactivation data for the
target pathogens were collected through an extensive literature review (Table 3). Studies that measured
actual pathogen concentrations and log removal values (LRV) in full-scale facilities were preferred and
used when possible. However, pathogen surrogates and pilot-scale or bench-scale studies were used
when no other information was available. In addition, studies that provided multiple data points for
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log removal or pathogen concentration were preferred so the treatment variability for the unit process
could be modeled.
Table 3. Monte Carlo parameters for treatment process log removal values.
Process Crytosporidium Reference Norovirus Reference Salmonella Reference
Conventional drinking water treatment
Coagulation + sedimentation + granular
media filtration N (2, 0.5)
a [25] N (2.1, 0.7) [26] N (1.77, 0.25) [25]
Chlorine disinfection N (0.41, 0.4) [24] N (1.68, 0.24) [27] N (2.57, 0.35) [27]
Conventional wastewater treatment b
Sedimentation + Activated sludge N (1.58, 1.3) c [28] N (2.1, 0.78) [29] N (3.32, 0.76) c [28]
Filtration - - N (0.5, 0.02) [30] - -
DPR advanced treatment processes
Microfiltration (MF) N (4.6, 0.96) [31] N (0.6, 0.1) [32] N (5.96, 1.47) [31]
Reverse osmosis (RO) N (4.5, 0.73) [33] N (4.3, 0.34) [34] N (6, 0.6) [35]
UV N (2.2, 1.17) [36] N (4.96, 0.85) [37] N (3.82, 0.34) [27]
Ozone 1.2 [38] 5.4 [39] 4.15 [39]
Biological activated carbon filtration (BAC) U (0,0.85) d [12,40–42] U (0, 1) [12] U (0.5, 2) [12,21]
Membrane bioreactor (MBR) N (4.3, 0.6) [43] N (5.10, 0.41) [44] N (6.26, 0.75) [27]
Nanofiltration (NF) e N (5.52, 0.51) [45] N (4, 0.1) [32] N (4.8, 0.6) [46]
a N = Normal distribution with parameters mean, standard deviation (µ, σ); b Undisinfected effluent used for
input to DPR trains and disinfected effluent discharged to environment in de facto scenario; c Includes filtration;
d U = Uniform distribution with parameters minimum, maximum; e Ultrafiltration values used.
2.4.1. Conventional Drinking Water Treatment Processes
Conventional drinking water treatment processes were modelled including coagulation/sedimentation,
granular media filtration, and chlorine disinfection. For Cryptosporidium, Harrington et al. [25]
conducted challenge experiments with Cryptosporidium and Salmonella using water from a Wisconsin
municipal pilot plant with dual-media filtration columns. Log removal values of 2 ± 0.5 and
1.77 ± 0.25 were calculated from a combination of coagulation, flocculation, sedimentation and
filtration of Cryptosporidium and Salmonella, respectively. The maximum (4.3 LRV) of the modeled
distribution is consistent with estimates from a previous review of up to LRV of 4 from conventional
drinking water treatment plants [47]. The modelled maximum LRV for Salmonella of 2.7 is comparable
with estimates up to the LRV of 3 derived from E. coli data [48,49]. Norovirus removal through
conventional drinking water treatment was modeled using a study of bench experiments using
a coagulation-rapid sand filtration process with recombinant norovirus virus-like particles in river
water [26]. The coagulant dose was 40 µM-Al of alum [26]. The estimated mean LRV (2.1) is consistent
with LRVs reported for bacteriophage MS2 from conventional drinking water treatment (between 1.5
and 2) [48].
Chlorination removals during conventional drinking water treatment were calculated based on
wastewater removal values measured by several studies. Samples taken at a full-scale plant in Florida
were used to calculate Cryptosporidium removals of 0.41 ± 0.4 logs. Log removals from Francy et al. [27]
during full-scale wastewater treatment for E. coli (mean equivalent to median 2.57 LRV, maximum LRV
assumed equivalent to 95th percentile at 3.15) and somatic coliphage (median 1.68 LRV, maximum
2.08 LRV) were assumed to be conservative inactivation estimates for drinking water treatment for
Salmonella and norovirus, respectively. F-specific coliphage data were reported by Francy et al. [27],
but were not used as some values were below the detection limit for calculating the log removal.
It was necessary to rely on coliphage data because limited information was available for norovirus
inactivation with free chlorine at pilot or full-scale facilities. Additionally, Francy et al. [27] did not
specify whether free or combined chlorine was used.
2.4.2. Conventional Wastewater Treatment Processes
Conventional wastewater treatment was considered to consist of a primary sedimentation process,
biological activated sludge, and granular media filtration. Rose et al. [24] report 1.14 log reduction of
Cryptosporidium from biological treatment at a full-scale water reclamation facility in Florida. Similarly,
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Ottoson et al. [28] reported a mean ± standard deviation of 1.58 ± 1.30 Cryptosporidium log removal
from a pilot plant in Stockholm, Sweden and Cheng et al. [50] reported removals ranging from 0.67 to
1.54 LRV. Due to the similarity in these estimates, the distribution that accounted for variability [28]
was used. For norovirus, data from a full-scale plant were used with an estimate of 2.1 ± 0.78 LRV [29].
A distribution of E. coli removals from Ottoson et al. [28] was used to represent Salmonella removal,
consistent with point estimates for removals in various systems [51,52].
2.4.3. Advanced DPR Treatment Processes
For the DPR advanced treatment processes, microfiltration (MF), reverse osmosis (RO), UV, ozone,
biological activated carbon filtration (BAC or BAF), membrane bioreactors (MBR), and nanofiltration
(NF) were the processes considered. Microfiltration log removal values of 4.6 ± 0.96 were reported by
Hong et al. [31] for Cryptosporidium from a pilot-plant with 0.2 µm nominal pore size polypropylene
filter in Tampa, Florida. This is consistent with a 4–7 log removal range reported by Reardon et al. [53]
for protozoa. In a bench-scale microfiltration experiment using recombinant norovirus particles
with a PVDF pore size of 0.1 µm, Matsushita et al. [32] observed LRV of 0.6 ± 0.1. For Salmonella,
Hong et al. [31] also observed an LRV of 5.96 ± 1.47 for E. coli. This is assumed to be representative of
Salmonella in the absence of other data and is consistent with the range reported for bacteria of up to
9 LRVs [53].
2.4.4. Reverse Osmosis Treatment Process
Reverse osmosis removal values for Cryptosporidium were reported for pilot-scale RO plants
challenge tested with non-viable Cryptosporidium oocysts. A mean and 95th percentile value were
derived from log-removal values under compromised membrane condition (4.5) or uncompromised
(5.7) membrane conditions, respectively [33]. For norovirus, Governal and Gerba [34] conducted
challenge tests of MS2 in a pilot-scale system with RO. The mean influent and effluent concentrations
for MS2 were 2.2 × 105 ± 1.3 × 105 and 1.2 × 101 ± 0.6 × 101 PFU/ml, respectively, and previously
described error propagation techniques [54] were used to determine a removal distribution (µ = 4.3,
σ = 0.34). MS2 was considered to be representative of norovirus removal. Data from a Gram negative
bacterium (Klebsiella terrigena) from a point-of-use RO-iodine resin water treatment system was used to
model Salmonella removal [35].
2.4.5. Ultraviolet and Ozone Disinfection Processes
UV-inactivation was measured in bench-scale experiments with Cryptosporidium spiked into
samples of filtered water from a water treatment plant for a range of UV doses (1.8–112 mJ/cm2)
and times; samples were tested using a neonatal mouse model for infectivity [36]. Log removal
values were averaged over the doses provided yielding a mean and standard deviation of 2.2 ± 1.17.
For norovirus, a bench-scale study of MS2 inactivation in tap water with and without H2O2 using
127 mJ/cm2 UV dose was used to determine a mean LRV of 4.96 ± 0.85 for a UV-only trial at flow
conditions of 2 gpm. To obtain a 4-log reduction for virus, 186 mJ/ cm2 dose is required for virus,
whereas for Cryptosporidium, a 22 mJ/cm2 dose is sufficient, and suggesting that the log removal
used for Cryptosporidium is likely very conservative [37]. Francy et al. [27] reported median and
maximum removal for E. coli of 3.82 and 4.38, which were considered representative of Salmonella.
Francy et al. [27] did not provide a UV dose, but it is noted that UV dosing at a DPR plant is likely
to be an order of magnitude higher than in a conventional wastewater treatment plant, to achieve
target removals of trace organics by AOPs. Data from Sherchan et al. [37] was used for norovirus as
opposed to Francy et al. [27] because these values were below the detection limit for assessing log
removal for norovirus. The maximum LRV was used as the 95th percentile in this assessment to derive
a normal distribution for both parameters. The estimated LRVs from these references are within a 0.5 to
4.0 log inactivation range for various UV doses provided by USEPA [55] (original reference Table 1.4).
While it is recognized that the LRV is sensitive to the UV dose, the guidance manual allows only point
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estimates to be determined at each UV dose, and does not provide information on process variability
that will occur in full-scale facilities.
Exposure to 5 mg-min/L ozone achieved 1-log inactivation in bench-scale experiments by
Korich et al. [56]. Limited full-scale information was available, however, and treatment due to ozone from
a Montreal treatment plant was >1.2 logs for the ozone treatment stage, therefore a point estimate of 1.2 logs
was used. Specific information about the ozone dose was not provided. Removal for male-specific (MS2)
coliphages was estimated by Tanner et al. [39] as 5.4 logs at 0.22 mg-min/L ozone [12]. Tanner et al. [39]
also estimated 4.15 log reductions in E. coli occur at 0.25 mg-min/L ozone [12].
2.4.6. Membrane Bioreactor (MBR) Wastewater Treatment Process
MBR removal values were obtained for Cryptosporidium from Marti et al. [43] from a pilot MBR
with a pore size of 0.4 µm. Sulphite-reducing Clostridium spores were used as a surrogate; log removal
values were plotted against transmembrane pressure (TMP) without any evidence of correlation.
The data point for TMP at 123 mbars was chosen as it represented the greatest variability of 4.3 ± 0.6
log removals. Chaudhry et al. [44] conducted a study of removal of norovirus GII in a full-scale
membrane bioreactor with a nominal pore size of 0.04 µm, finding a LRVs of 5.10 ± 0.41. In a study of
MBR removal from five full-scale wastewater plants, Francy et al. [27] reported median and maximum
removal for Enterococcus of 6.26 and 7.49 LRVs, respectively. E. coli data were not used as effluent
concentrations were below the detection limit for calculating the log removal. The maximum was
used as the 95th percentile in this assessment to derive a normal distribution for both parameters.
Enterococci were considered representative of Salmonella.
2.4.7. Unit Process LRV Literature Gaps
Several areas were particularly challenging for assigning LRVs. In particular, BAC had limited
information available. As a result, assumptions from a previous risk assessment were maintained for the
removals from all the index pathogens [12]. For NF, in the absence of other data, ultrafiltration values were
used. Beauchamp et al. [45] conducted a study of log removal values based on integrity pressure-decay
tests (detecting holes of 3 µm or more) in a full-scale ultrafiltration plant. These values were used to define
a Cryptosporidium log removal distribution of 5.52 ± 0.51. Gómez et al. [46] conducted measurements
in pilot-scale plants using secondary treated (after activated sludge) wastewater for sand filtration and
ultrafiltration using E. coli. A LRV of 4.8 ± 0.6 was estimated and considered representative of Salmonella.
Using recombinant norovirus particles in a bench-scale filtration apparatus (UF regenerated cellulose
with a molecular weight cutoff of 1 kDA), Matsushita et al. [32] conducted triplicate experiments with
dead-end filtration of river water, observing LRV of 4 ± 0.1.
2.5. Risk Model
A QMRA was conducted to capture typical operational variation using a previously derived
framework [57]. Equations for de-facto reuse water and DPR water without considering blending into
additional drinking water processes are given by Equations (1) and (2), respectively, where reference
pathogen ref = norovirus, Cryptosporidium, or Salmonella arriving at the consumer (Cconsumer,ref):
Cconsumer,re f = 10
−LDW,re f
[
FdilutionCww,raw10
−LWW,re f
]
(1)
Cconsumer,re f = Cww,raw10
−LDPR, t,re f (2)
For scenarios where de-facto water and DPR water are blended and further downstream drinking
water treatment is considered after the DPR trains, the risks were modelled using Equation (3):
Cconsumer,re f = 10
−LDW,re f
{[
FdilutionFblendCww,raw10
−LWW,re f
]
+
[
(1− Fblend)Cww,raw10−LDPR, t,re f
]} (3)
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where Cww,raw = concentration of pathogen ref in raw wastewater influent (pathogens per L),
Fdilution = Dilution factor for conventionally treated wastewater effluent in pristine surface water,
Fblend = Portion of surface water blended with DPR effluent water prior to conventional drinking water
treatment LDW = total log removals of pathogen ref due to conventional drinking water treatment,
Lww= total log removals for pathogen ref due to conventional wastewater treatment, and LDPR = total
log removals for pathogen ref due to a given treatment train. The log removals of pathogen ref due to
treatment processes are given by Equations (4) through (6):
LDW = ∏n1 Pi,re f (4)
where Pi = log reductions for reference pathogen ref for conventional drinking water treatment train
removal process i;
LWW = ∏n1 Pi,re f (5)
where Pi = log reductions for reference pathogen ref for conventional wastewater treatment train
removal process i;
LDPR = ∏n1 Pi,re f (6)
where Pi = log reductions for reference pathogen ref for a given DPR train removal process i.
The following cases for Equation (3) are considered:
a. When Fblend = 0, only DPR trains are considered and no blending with de facto reuse source water
is considered, but DPR effluent undergoes additional conventional drinking water treatment;
b. Fblend = 1, only de facto reuse is considered;
c. For 0 < Fblend < 1, DPR water is blended with de facto reuse source water prior to conventional
drinking water treatment.
For cases b and c, 0 < Fdilution < 1 where 0 is pristine, pathogen-free source-water, and 1 is source
water comprised of 100% conventionally-treated wastewater effluent. In a 2008 USEPA model of the
top 25 most impacted drinking water treatment plants in the nation, under low streamflow conditions,
wastewater effluent constituted between 7 and 100% of the total source water volume [58]. For this
reason, in the absence of the use of a specific waterbody, Fdilution was simulated over the entire potential
range of qualities from 0 to 100% effluent-impacted source water. It is recognized that utilities must
comply with outgoing effluent requirements; this is a hypothetical case to explore a range of possible
scenarios under various source water conditions and understand the primary drivers of microbial risk
when DPR is considered. A daily dose for each reference pathogen was computed using Equation (7):
Dre f = Cconsumer,re f Ving (7)
where Dref = daily dose of reference pathogen ref and Ving = volume of drinking water ingested per day.
The daily probability of infection for each pathogen ref was computed using dose response models
provided in Equation (8) (Cryptosporidium), (9) (Salmonella), and (10) (norovirus):
Pin f ,daily,Cr = 1− e−rDCr (8)
where r is the exponential dose response parameter [9];
Pin f ,daily,Sa = 1− (1 + DSaβ )
−α
(9)
where α and β are parameters of the Beta-Poisson dose response model [9];
Pin f ,daily,No = P(1− e
−DNo
u ) (10)
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where Equation (10) describes the fractional Poisson model [59] and P and µ are parameters of the
model describing the perfectly susceptible fraction of secretor status positive (Se+) individuals and
mean aggregate size, respectively. Both aggregated and disaggregated forms of the norovirus dose
response model are considered in order to provide a range of predicted outcomes as the selection of
norovirus dose response model has been shown to yield meaningful differences in risk estimates at
low norovirus doses [60]. Exposure and dose response parameters are summarized in Table 4.
Total daily infection risks for each reference pathogen were calculated according to Equation (11).
A similar approach has been used to pool risks from multiple pathogens by previous QMRA
studies [12,61,62].
Pin f , daily,total = 1−
nre f
∏
1
(
1− Pin f , daily,re f
)
(11)
Table 4. Monte Carlo simulation input parameters for exposure and dose response.
Parameter Symbol Unit Value Distribution Source
Intake rate Ving,dw L per day
µ = −0.630,
σ = 0.989 Lognormal
a [63]
Exposure frequency ndw times per year 365 Point Assumption
Cryptosporidium
dose response r Unitless 4.19 × 10
−3 Point [9]
Norovirus dose
response- aggregated
P Unitless 0.72 Point
[59]
µ Unitless 1106 Point
Norovirus dose
response-disaggregated
P Unitless 0.72 Point
[59]
µ Unitless 1 Point
Salmonella nontyphoid
dose response α Unitless 0.3126 Point [9]
β Unitless 2884 Point
a Lognormal parameters mean, standard deviation (µ, δ) calculated from population (normal) parameters (x, s)
using standard formulae as follows: µ = ln(x2/(s2+x2)1/2), δ = [ln(1+(s2/x2))]1/2, where x is the sample mean and s2
is the sample standard deviation.
2.6. Risk Characterization
Annual risk was calculated as per Equation (12), where n is the yearly frequency of the activity:
Pin f , annual,re f = 1−
n
∏
1
(
1− Pin f ,daily,re f
)
(12)
A sensitivity analysis was conducted to identify variables contributing to uncertainty using
100,000 Monte Carlo iterations. All computations were performed in R (www.rproject.org) and using
the mc2d package [64]. Random sampling of daily risks with replacement was conducted as per the
preferred method for annualizing probability of infection using 100,000 iterations [65].
The Spearman rank correlation coefficient was used to identify the most important predictive
factors of annual infection or clinical severity infection risk, were 0 is no influence and −1 or +1 when
the output is wholly dependent on that input. The model inputs were ranked based on their correlation
coefficient with the output variable, annual risk.
3. Results
3.1. Comparison of Microbial Risks for DPR Configurations and de Facto Reuse
A comparison of annual risks for treatment scenarios (1) through (5) is shown in Figure 2.
The de-facto reuse scenario (1) shown is for a low-level contamination scenario (source water
comprised of 10% treated secondary wastewater effluent; on the low end of the 7–100% range given
by Rice et al. [58]). With a small degree of wastewater impact to the source water, risk from de-facto
scenarios were up to 11 orders of magnitude higher than DPR treatment train effluents. Furthermore,
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the risk shown for DPR treatment trains in Figure 2 do not include further log reductions due to
downstream drinking water treatment [6]. The only scenarios above a 10−4 annual risk benchmark
were the de-facto reuse scenarios for Cryptosporidium, norovirus (using a disaggregated dose response
model), and a combination of all three pathogens (Cryptosporidium, norovirus, and Salmonella). Use of
an aggregated vs. a disaggregated dose response model for norovirus had a difference of approximately
3 orders of magnitude in annual risk, with aggregated risks being lower. The rank order of median
annual risks computed for the various treatment trains scenarios was: de-facto reuse > scenario (2)
> scenario (4) > scenario (3) > scenario (5). Total pathogen risks were dominated by Cryptosporidium
and norovirus estimates; however, the rank order of these risks varied depending upon the treatment
train and dose response model used for norovirus. For scenarios (3)–(5), the risk from norovirus
(disaggregated) was lower than Cryptosporidium, but the opposite was true for scenarios (1)–(2).
Due to lack information on norovirus aggregation behavior during full-scale treatment processes,
the difference in aggregation state was considered for the dose response models but not for the
LRV parameters.
Int. J. Environ. Res. Public Health 2017, 14, 635  13 of 23 
 
(disaggregated) was lower than Cryptosporidium, but the opposite was true for scenarios (1)–(2). Due 
to lack information on norovirus aggregation behavior during full-scale treatment processes, the 
di fer  i  ag regation state was considere  for the dose respons  m dels but not for he LRV 
ra eters.  
 
Figure 2. Comparison of annual risks for treatment scenario (1) (de facto reuse) and direct potable 
reuse (DPR) scenarios (2) through (5), without additional downstream conventional drinking water 
treatment for the DPR trains. The de facto reuse scenario assumes that 10% of surface water is 
comprised of secondary treated wastewater effluent. Boxes show 25th, 50th, and 75th percentiles 
while whiskers extend to the 5th and 95th percentiles. Note that Salmonella annual infection risks for 
Train 5 are < 10−14. 
3.2. Impact of Treatment Stages on Annual Risk 
A comparison of annual risks of each treatment train as they progress through the treatments 
processes is shown in Figure 3. Train 1 (de-facto reuse) has lower starting risks for Salmonella and 
norovirus-aggregated compared to the other treatment trains because the starting matrix is secondary 
treated wastewater effluent-impacted surface water rather than raw wastewater, and the 
concentrations of pathogens are therefore lower. Additionally, no reduction in median annual 
Figure 2. Comparison of annual risks for treatment scenario (1) (de facto reuse) and direct potable reuse
(DPR) scenarios (2) through (5), without additional downstream conventional drinking water treatment
for the DPR trains. The de facto reuse scenario assumes that 10% of surface water is comprised of
secondary treated wastewater effluent. Boxes show 25th, 50th, and 75th percentiles while whiskers
extend to the 5th and 95th percentiles. Note that Salmonella annual infection risks for Train 5 are <10−14.
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3.2. Impact of Treatment Stages on Annual Risk
A comparison of annual risks of each treatment train as they progress through the treatments
processes is shown in Figure 3. Train 1 (de-facto reuse) has lower starting risks for Salmonella and
norovirus-aggregated compared to the other treatment trains because the starting matrix is secondary
treated wastewater effluent-impacted surface water rather than raw wastewater, and the concentrations
of pathogens are therefore lower. Additionally, no reduction in median annual infection risk for
the activated sludge process is visible for Train 2 through 5 and minimal reductions are observed
for norovirus-disaggregated in some other early treatment stages. In the early treatment stages,
concentrations of pathogens can still be high after a given treatment process, and the risk may still
therefore be close to 1 even if there has been a pathogen reduction, resulting in only small or nonexistent
differences in Figure 3.
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Table 5. Sensitivity analysis with Spearman rank correlation coefficients for DPR treatment trains.
Parameter
Cryptosporidium Norovirus-Disagg. Norovirus-Agg. Salmonella
2 3 4 5 2 3 4 5 2 3 4 5 2 3 4 5
Wastewater concentration (Cww,raw) 0.17 0.16 0.24 0.14 0.002 0.005 0.011 −0.001 −0.006 −0.006 −0.002 0.0001 0.092 NA a 0.277 NA
Contact rate (Ving,dw) −0.004 −0.005 0.003 −0.003 −0.0004 0.002 0.004 −0.003 −0.001 −0.001 −0.005 0.005 0.0004 0.005
Chlorine disinfection −0.17 −0.16 −0.24 −0.14 −0.19 −0.17 −0.22 −0.16 −0.19 −0.05 −0.22 −0.04 −0.03 −0.09
Conventional ww treatment −0.56 −0.52 −0.45 −0.62 −0.62 −0.55 −0.61 −0.14 −0.12 −0.06
MF −0.41 −0.39 −0.33 −0.08 −0.06 −0.07 −0.08 −0.02 −0.02 −0.09
RO −0.32 −0.28 −0.44 −0.26 −0.24 −0.32 −0.26 −0.07 −0.31 −0.04 −0.15
UV −0.50 −0.47 −0.71 −0.40 −0.68 −0.61 −0.81 −0.61 −0.67 −0.15 −0.81 −0.12 −0.03 −0.08
BAC −0.10 −0.08 −0.21 −0.20 −0.06 −0.05
MBR −0.36 −0.39 −0.38 −0.17
NF −0.18 −0.07 −0.02
a NA = not applicable, risks below calculation limits; b For norovirus only.
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This comparatively small reduction in earlier treatment trains is especially apparent for the
norovirus-disaggregated estimates (for example, Figure 3 train 2). This is due to the fact that
the Fractional Poisson disaggregated dose response model will predict higher risks at low doses
compared to other available norovirus dose response models; risk curves for scenarios modeled
by van Abel et al. [60] using the disaggregated model show a flatter curve when the dose is below
100 gene copies compared to scenarios modeled using the aggregated model (see original reference
Figure 1). It is worth noting that several studies have documented virus aggregation in natural
waters [41,44,66].
The predicted risks will therefore be high with the disaggregated model until the dose reaches
a lower level, at which point the risk decreases more rapidly, and it is easier to see the risk difference
from one treatment stage to the next. Membrane-based treatment processes were generally the most
effective at reducing pathogen risk in all scenarios. RO had the most significant impact on risk
reduction for trains (2) through (4) while MF and NF had the most significant impact on removal
in train (5). However, it is noted that the benefit of RO removal is less influential for disaggregated
norovirus risk estimates due to the caveats related to the norovirus-disaggregated dose response model
described above [60]. A sensitivity analysis is shown in Table 5 for the DPR scenarios and supports
that RO is an influential predictor of protozoan and virus risks (Spearman rank correlation coefficient
ranging from −0.28 to –0.44 for Cryptosporidium, −0.07 to –0.32 for norovirus) but is less influential for
Salmonella removal (−0.04 to –0.15). In all cases, the removal processes were more influential than the
starting concentration of pathogens in wastewater and the rate of drinking water consumption (in L per
day consumed) was not an important predictor. Removal by UV, conventional wastewater (activated
sludge, settling, and filtration) processes, MBR, and MF were also influential treatment steps for their
respective treatment trains. For conventional surface water, the degree of wastewater impact will vary
depending on local conditions. To explore the effect of surface water quality on risks due to de facto
reuse, annual risks were simulated over the full range from zero to 100% wastewater effluent, without
considering die-off or additional pathogen sources to the surface water (Figure 4). By definition, the
lowest risk was observed for 0% effluent in surface water or for pristine, pathogen-free source water.
The greatest increase in annual risks occurred between 0% and 10% effluent-impacted source water
and little increase in risk was observed beyond 20% effluent-impacted source water.
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Figure 4. Impact of surface water quality on DPR risk modeled as percent of source (surface) water
comprised of secondary treated wastewater effluent (Treatment train scenario (1), de facto reuse, case b,
Fblend = 1, 0 < Fdilution < 1). Median annual risks shown for each pathogen. Microbial risk is driven by
surface water quality even when supplies are impacted by 1% secondary treated wastewater effluent.
3.3. Impact of Blending Advanced-Treated DPR Water and Wastewater-Impacted Surface Water
The impacts of blending 50% secondary wastewater effluent-impacted surface water (de facto
reuse) with DPR water having underdone advanced treatment prior to drinking water treatment
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are shown in Figure 5 and Supplemental Figure S1. Blending with surface water at this point in the
treatment process is currently used at the Big Spring, TX water reclamation plant [6]. Changes in
water quality were greatest up to approximately 10% blending of de facto water with DPR water
and demonstrate that small additions of de facto water (as low as 1%) have significant impacts on
computed DPR risks.
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Figure 5. Impact of blending DPR water with 50% effluent-impacted surface water for treatment
Train 3, case c, Fdilution = 0.5, 0 < Fblend < 1. Microbial risk is driven by surface water quality (not DPR
water) for all scenarios (scenarios for train 2, 4, and 5 produced highly similar results and are shown in
Supplemental Figure S1). Even blending 1% of i ted surface water increases consumer risk.
4. Discussion
The idea of using wastewater to augment drinking water supplies has historically faced opposition
from the general public, and blending advanced treated wastewater with surface water supplies is one
way to demonstrate that the supply is not dominated with water of wastewater origin [67]. However,
surface water supplies may already be impacte with wastewater effluent from upstream communities.
Wastewater efflu nts discharged in o environmental waters are not required to e su jected to
advan ed treatment such as reverse osmosis and arious membrane-based technologies (33 UCS
§ 1342, 2002), so impacted rivers and surface waters can potentially contain higher concentrations
of pathogens than advanced-treated waters. Under the conditions investigated, unintentional
reuse (scenario (1)) posed risks of infection greater than the 10−4 benchmark for norovirus and
Cryptosporidium, and blending this surface water with advanced-treated water resulted in similar
risks, as the risks were dominated by the surface water. This analysis does not apply to communities
that have access to relatively pathogen-free water sources through protected watersheds or deep
aquifer groundwater, but is relevant for communities using surface water downstream of wastewater
discharges. As changes in climate patterns make the supply of surface water less reliable and urban
populations grow, the quality of the surface water used for blending will become an even greater
concern. Strategies for mitigating risk could include monitoring the quality of the surface water used for
blending. Direct potable reuse without surface water blending (or blending with high quality surface
water) appears to present a lower risk of infection to the consumer by the target organisms modeled
than de facto reuse. Many decisions regarding treatment units, cost, protection of public health and
feasibility need to be made as the industry moves towards water reuse as a critical component of the
urban water portfolio.
This analysis provides a framework to compare different treatment scenarios by health risk as
a tool for decision-making in the design of reuse projects. For a specific location, this analysis can
provide a starting point for additional risk modeling using location specific pathogen concentrations.
For each treatment train, the most representative removal and inactivation for the target pathogens
Int. J. Environ. Res. Public Health 2017, 14, 635 15 of 20
was used. However, this analysis highlights the importance of additional information for pathogen
inactivation under full-scale conditions, especially for viruses in NF and and RO, and protozoan and
virus removals via UV, chlorine, and ozone. Because removal by disinfection processes is a function of
the dose, better approaches for accounting for disinfectant dose are needed to allow full-scale removal
data (which accounts for process variability) collected under one target dose to be extrapolated to other
doses. These data gaps are especially notable as these processes were identified as highly influential on
DPR train performance in a process-by-process assessment of health risks and ultrafiltration LRVs had
to be used as surrogates for NF. In some cases, surrogates were used (such as MS2 or E. coli); while this
practice is appropriate for QMRA, additional research is needed to quantify the removal/inactivation
of actual pathogens under full-scale conditions. In particular, the aggregation state of norovirus can
have a large impact on risk estimates [60]. Additionally, the removal and inactivation of norovirus
by various unit processes may be different depending on its aggregation state as has been noted in
some bench-scale studies indicating the importance of solution chemistry [68]. Aggregation state can
have potential impacts on estimated process LRVs [69]. However, little information is available on
the effect of aggregation for the various full-scale treatment processes of interest in the current Monte
Carlo models. Therefore, the state of aggregation was considered for the dose response models but not
the treatment scenarios (LRVs). The impact of the various full-scale treatment processes on potential
aggregation of norovirus and resulting risks is a research gap that remains to be addressed. It is noted
that log removal values for specific treatment facilities vary and the focus of this assessment was to
examine comparative, rather than absolute risks.
Limited information is available for actual blending ratios likely to be used, and the
specific location of blending within the treatment train. This QMRA indicates that source water
quality is an extremely influential parameter when blending advanced-treated DPR water with
wastewater-impacted source water. Limiting the percentage of surface water impacted with sewage
effluent may not be feasible depending on local conditions. This analysis also assumed background
“pristine” waters and that there were no additional pathogen loads, such as from stormwater or
agricultural sources. However, these inputs are common and could be included in a more detailed
consideration of pathogens in source waters, accounting for fate and transport. The desired blending
ratio is dependent on the source water quality; however, the current analysis indicates that for a source
water quality impacted by 50% secondary wastewater effluent, a blending ratio < 1% can still have
large impacts on modelled risks.
The potential impact of recovery efficiencies of the various analytical methods used to measure
pathogen removals was not considered in this analysis, and all studies used as input parameters
considered the measured organisms to be viable and infectious. Therefore, comparing measurements
made via culture (Salmonella) with those made via qPCR (norovirus) can introduce some inaccuracies
in the model. However, the dose response models used for each of these organisms used culture
and qPCR, respectively, indicating harmonization between these parameters. Still, overestimation
of norovirus viability and infectivity, and underestimation of Salmonella or Cryptosporidium risks
associated with culture or fluorescence-based methods could have occurred.
In the cases considered, de facto risks exceeded benchmarks while advanced-treated DPR water
risks were below these values. It was assumed that the log removal values modeled were representative
of removal achieved in full-scale facilities, and furthermore that distributions for log removals
encompassed typical variations in operation, maintenance, and design for the various treatment
processes and can be generalized. Furthermore, we assumed that no changes in water quality occurred
during storage or distribution; this is a limitation as these stages are known to impact water quality.
In a similar analysis conducted by Soller et al. [12], risks were analyzed for various DPR treatment
trains using uniform distributions of input parameters. The authors similarly noted annual risks below
10−4 for varying treatment trains and that the use of DPR can provide public health benefits when
blended with conventionally treated waters. Results from a QMRA by Lim et al. [15] of de facto reuse
in Trinity River, Texas also indicated that de facto risks exceeded traditional benchmarks, with the
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caveat that disease burdens may be within allowable limits using World Health Organization Disability
Adjusted Life Year (DALY) benchmarks.
Finally, a key limitation and area for further exploration is regarding the assumption of
independence of treatment processes and lack of catastrophic treatment failures considered in the
current model. The reliability of various treatment approaches have been modelled for individual
components including MBR [70] as well as overall reliability for general de facto reuse [71], water
and wastewater treatment [72–74], and distribution system main breaks [75]. This analysis provides
a flexible framework that can be combined with information on likelihood of treatment lapses in order
to expand upon the current work using a dynamic probabilistic framework.
5. Conclusions
Data for pathogen removal by full-scale facilities were not available for all processes; surrogate
information was used in several cases (MS2 for norovirus or E. coli for Salmonella, for example).
Particular data needs include a method for determining disinfectant dose-specific inactivation values
that capture the variability of disinfection processes (chlorine, ozone, UV) at full-scale; norovirus log
removal by granular media filtration and RO; Salmonella removal due to RO treatment; Cryptosporidium
removal in membrane bioreactors; and NF for all pathogens. Improving these data inputs will help to
refine risk estimates and therefore provide more robust information for DPR risk management.
Modelled de facto reuse scenarios exceeded risk benchmarks (10−4) while DPR treatment trains
were several orders of magnitude below the risk benchmark. Modeled infection risks for blending de
facto reuse water with DPR finished water were driven by contamination levels in the surface water
sources and not by the DPR treatment trains. Risks for de facto reuse were driven by the source water
quality; with a source water quality impacted by 50% secondary wastewater effluent, a blending ratio
<1% can still have large impacts on modelled DPR risks.
Analysis assumed no catastrophic integrity failures in the advanced treatment systems but
incorporated typical process variability. This framework for analyzing health impacts of DPR can be
expanded to include treatment failures (e.g., via dynamic probabilistic methods).
Supplementary Materials: The following are available online at www.mdpi.com/1660-4601/14/6/635/s1,
Figure S1: Impact of blending DPR water with 50% effluent-impacted surface water. In all treatment scenarios,
microbial risk is driven by surface water quality (not DPR water). Even blending 1% of impacted surface water
increases consumer risk.
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